News Focus
News Focus
Post# of 257271
Next 10
Followers 54
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

Re: DewDiligence post# 102773

Friday, 08/27/2010 8:09:25 PM

Friday, August 27, 2010 8:09:25 PM

Post# of 257271
Since there has been no listed approval for 3rd line I'm aware of, having the FDA say there are approved thereapies USED in 3rd line as a reson for the RTF would be a significant change in interpretation of accelerated approval rules.

I'll note Pazdur has precedent for this. His requirement that confirmatory trials be "substantially" underway prior to granting accelerated approval is nowhere in the regs. In fact, it goes against Congressional intent.

Unless otherwise indicated, this is the personal viewpoint of David
Miller and not necessarily that of Biotech Stock Research, LLC.
We're on Twitter at BiotechStockRsr

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today